These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28292352)

  • 1. Prevalence and Risk Factors Associated with Adverse Drug Reactions among Previously Treated Tuberculosis Patients in China.
    Han XQ; Pang Y; Ma Y; Liu YH; Guo R; Shu W; Huang XR; Ge QP; DU J; Gao WW
    Biomed Environ Sci; 2017 Feb; 30(2):139-142. PubMed ID: 28292352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug reactions in tuberculosis and management.
    Prasad R; Singh A; Gupta N
    Indian J Tuberc; 2019 Oct; 66(4):520-532. PubMed ID: 31813444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence, Management, and Risk Factors for Adverse Drug Reactions in Multidrug Resistant Tuberculosis Patients.
    Ahmad N; Javaid A; Syed Sulaiman SA; Afridi AK; Zainab ; Khan AH
    Am J Ther; 2018; 25(5):e533-e540. PubMed ID: 26938643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.
    P V K; Palaian S; Ojha P; P R S
    Pak J Pharm Sci; 2008 Jan; 21(1):51-6. PubMed ID: 18166520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of adverse reactions induced by anti-tuberculosis drugs among hospitalized patients in Wuhan, China: A retrospective study.
    Shi C; Yang B; Yang J; Song W; Chen Y; Zhang S; Zhan H; Xiong Y; Rong P; Luo Y; Yang J
    Medicine (Baltimore); 2024 May; 103(20):e38273. PubMed ID: 38758847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with anti-TB drug-induced hepatotoxicity and genetic polymorphisms in indigenous and non-indigenous populations in Brazil.
    Heinrich MM; Zembrzuski VM; Ota MM; Sacchi FP; Teixeira RL; Cabello Acero PH; Cunha GM; Souza-Santos R; Croda J; Basta PC
    Tuberculosis (Edinb); 2016 Dec; 101():15-24. PubMed ID: 27865386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study.
    Choi H; Park HA; Hyun IG; Kim JH; Hwang YI; Jang SH; Sim YS; Shin TR; Ko Y; Ban GY; Hong JY; Lee CY; Lee MG; Choi JH
    Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1153-1163. PubMed ID: 35909258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between lncRNA AC079767.4 variants and liver injury from antituberculosis treatment in West China.
    Zhao Z; Peng W; Wu L; Ying B
    J Infect Chemother; 2020 Jan; 26(1):63-68. PubMed ID: 31405785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the change in the antitubercular regimen from three to four drugs on cure and frequency of adverse reactions in tuberculosis patients from Brazil: A retrospective cohort study.
    Arriaga MB; Torres NMC; Araujo NCN; Caldas SCC; Andrade BB; Netto EM
    PLoS One; 2019; 14(12):e0227101. PubMed ID: 31877199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China.
    Mi F; Tan S; Liang L; Harries AD; Hinderaker SG; Lin Y; Yue W; Chen X; Liang B; Gong F; Du J
    Trop Med Int Health; 2013 Nov; 18(11):1379-85. PubMed ID: 24112411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors.
    Javadi MR; Shalviri G; Gholami K; Salamzadeh J; Maghooli G; Mirsaeedi SM
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1104-10. PubMed ID: 17823987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
    Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
    Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of adverse reactions caused by first-line anti-tuberculosis drugs and treatment outcome of pulmonary tuberculosis patients in Morocco.
    El Hamdouni M; Ahid S; Bourkadi JE; Benamor J; Hassar M; Cherrah Y
    Infection; 2020 Feb; 48(1):43-50. PubMed ID: 31165445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study.
    Lv X; Tang S; Xia Y; Wang X; Yuan Y; Hu D; Liu F; Wu S; Zhang Y; Yang Z; Tu D; Chen Y; Deng P; Ma Y; Chen R; Zhan S
    PLoS One; 2013; 8(6):e65037. PubMed ID: 23750225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.
    Yee D; Valiquette C; Pelletier M; Parisien I; Rocher I; Menzies D
    Am J Respir Crit Care Med; 2003 Jun; 167(11):1472-7. PubMed ID: 12569078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the prevalence and effect of adverse drug reactions among patients receiving first line anti-tubercular medicines in the Tamale Teaching Hospital, Ghana.
    Amalba A; Bugri AA
    Pan Afr Med J; 2021; 38():191. PubMed ID: 33995797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
    Bhushan B; Chander R; Kajal NC; Ranga V; Gupta A; Bharti H
    Indian J Tuberc; 2014 Oct; 61(4):318-24. PubMed ID: 25675695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).
    Xia YY; Hu DY; Liu FY; Wang XM; Yuan YL; Tu DH; Chen YX; Zhou L; Zhu LZ; Gao WW; Wang HY; Chen da F; Yang L; He PP; Li XT; He YJ; Sun F; Zhan SY
    BMC Public Health; 2010 May; 10():267. PubMed ID: 20492672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced hepatotoxicity of anti-tuberculosis drugs and their serum levels.
    Jeong I; Park JS; Cho YJ; Yoon HI; Song J; Lee CT; Lee JH
    J Korean Med Sci; 2015 Feb; 30(2):167-72. PubMed ID: 25653488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.